Streetbeat News

Products Services

ATHM

CANG

UXIN

Cango Inc. (NYSE:CANG) is shifting its business model to focus on exporting used Chinese cars and providing related services, moving away from direct car trading. This strategic pivot comes as China's domestic car market slows, and Cango aims to capitalize on the growing global demand for Chinese vehicles. Despite a significant drop in revenue, Cango's stock has risen 74% this year, contrasting with declines in competitors Autohome (NYSE:ATHM) and Uxin (NASDAQ:UXIN).

Portfolio Pulse from The Bamboo Works

September 05, 2024 | 3:25 pm

MRK

Merck has completed negotiations with the pan-Canadian Pharmaceutical Alliance for WELIREG, a treatment for certain conditions associated with von Hippel-Lindau disease. The next step involves provincial and territorial governments implementing reimbursement.

Portfolio Pulse from Benzinga Newsdesk

September 05, 2024 | 3:22 pm

BMWYY

F

Major automakers like Volkswagen, BMW, and Ford are exploring the use of hemp in vehicle manufacturing to enhance sustainability and reduce carbon emissions. This initiative aligns with the growing demand for eco-friendly products.

Portfolio Pulse from El Planteo

September 05, 2024 | 3:21 pm

LIF

UBER

Life360 has launched a new advertising platform in the U.S., focusing on privacy-first targeting using family insights and location data. Uber is a key partner, offering targeted ads and integrated transportation options for teens with parental supervision.

Portfolio Pulse from Benzinga Newsdesk

September 05, 2024 | 3:19 pm

SHPH

Shuttle Pharmaceuticals (SHPH) shares experienced significant volatility, initially rising by 44% in pre-market trading before falling by 1.69% to $2.33. This movement followed the announcement of a new U.S. patent for selective histone deacetylase inhibitors, which are being developed for cancer and other diseases.

Portfolio Pulse from Henry Khederian

September 05, 2024 | 3:18 pm

ULTA

Ulta Beauty (NASDAQ:ULTA) has seen a surge in options trading activity, with a mix of bullish and bearish sentiment among investors. The options activity suggests a potential price range of $170 to $450. Analysts have varied opinions, with price targets ranging from $300 to $500.

Portfolio Pulse from Benzinga Insights

September 05, 2024 | 3:16 pm

LLY

Eli Lilly's shares are trading lower following the announcement of topline results from the QWINT-1 and QWINT-3 phase 3 clinical trials. These trials evaluated the once-weekly insulin efsitora alfa in adults with type 2 diabetes.

Portfolio Pulse from Benzinga Newsdesk

September 05, 2024 | 3:16 pm

FXI

MAR

Marriott's CEO highlighted challenges in implementing an aggressive pricing strategy in Greater China due to short booking windows. This could impact Marriott's revenue strategies in the region.

Portfolio Pulse from Benzinga Newsdesk

September 05, 2024 | 3:12 pm

APLD

NVDA

Applied Digital Corp. shares surged by 62.7% following a $160 million private placement financing deal. The investment, involving NVIDIA and Related Companies, will fund data-center and AI cloud infrastructure expansion, enhancing Applied Digital's position in AI and HPC sectors.

Portfolio Pulse from Vaishali Prayag

September 05, 2024 | 3:00 pm

BNO

USO

Oil prices are rising as OPEC+ is reportedly close to agreeing on delaying its planned output increase. This development is likely to impact oil-related ETFs such as BNO and USO.

Portfolio Pulse from Benzinga Newsdesk

September 05, 2024 | 2:43 pm